Clinical Evaluation Using Magnetic Resonance Imaging for Patients with Stage III Cervical Carcinoma Treated by Radiation Alone in Multicenter Analysis: Its Usefulness and Limitations in Clinical Practice

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 6, 2003, Pages 574-583

  Kodaira, Takeshi ^a   Fuwa, Nobukazu ^a   Toita, Takafumi ^b   Nomoto, Yoshihito ^c   Kuzuya, Kazuo ^a   Tachibana, Kazuyuki ^a   Furutani, Kazuhisa ^a   Ogawa, Kazuhiko ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; MRI; Pelvic fixation; Radiation therapy; Tumor volume

Indexed keywords

CESIUM; IRIDIUM; RADIUM;

ADULT; AGED; ARTICLE; BONE NECROSIS; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; FEMALE; FEMUR HEAD; GYNECOLOGIC CANCER; HUMAN; HYDRONEPHROSIS; IMAGING SYSTEM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PROGNOSIS; PUBIC BONE; RECTUM DISEASE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS;

EID: 0348134797     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000045811.97903.2A     Document Type: Article

References (41)

1. Mayr NA, Yuh WT, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997;39: 395-404.
2. Martin AJ, Poon CS, Thomas GM, et al. MR evaluation of cervical cancer in hysterectomy specimens: correlation of quantitative T2 measurement and histology. J Magn Reson Imaging 1994;4:779-86.
3. Oellinger JJ, Blohmer JU, Michniewicz K, et al. Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol 2000;122:82-91.
4. Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 1997;278:1096-101.
5. Hatano K, Sekiya Y, Araki H, et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1999;45:639-44.
6. Manfredi R, Maresca G, Smaniotto D, et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1998;209: 819-24.
7. Toita T, Kakinohana Y, Shinzato S, et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys 1999;43:777-82.
8. Hricak H, Quivey JM, Campos Z, et al. Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993;27: 791-801.
9. Mayr NA, Yuh WT, Zheng J, et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol 1998;170:177-82.
10. Kodaira T, Fuwa N, Kamata M, et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy? Int J Radiat Oncol Biol Phys 2002; 52:627-36.
11. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for highrisk cervical cancer. N Engl J Med 1999;340:1137-43.
12. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
13. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
14. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
15. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340: 1154-61.
16. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
17. Kim SH, Kim SC, Choi BI, et al. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 1994; 190:807-11.
18. Morita K. Cancer of the cervix. In: Vahrson HW, Brady LW, Heilmann H-P. Radiation oncology of gynecological cancers. Berlin: Springer, 1997:169-73.
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
20. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
21. Cox DR. Regression models and life table. J R Stat Soc 1972;34:197-220.
22. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
23. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69:2796-806.
24. Hricak H. Magnetic resonance tumor volumetry in cervical cancer. Int J Radiat Oncol Biol Phys 1996;35:1113-4.
25. Eifel PJ, Morris M, Wharton JT, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16.
26. Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 1993;17:633-40.
27. Mayr NA, Tali ET, Yuh WT, et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 1993;189:601-8.
28. Hricak H, Lacey CG, Sandles LG, et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988;166: 623-31.
29. Burghardt E, Hofmann HM, Ebner F, et al. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol. 1989;33:61-67.
30. Hawnaur JM, Johnson RJ, Buckley CH, et al. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol 1994;49:443-52.
31. Kovalic JJ, Perez CA, Grigsby PW, et al. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991;21:905-10.
32. Arthur D, Kaufman N, Schmidt-Ullrich R, et al. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1995;31:743-51.
33. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-75.
34. Chao KS, Williamson JF, Grigsby PW, et al. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:397-403.
35. Lambin P, Kramar A, Haie-Meder C, et al. Tumour size in cancer of the cervix. Acto Oncol 1998;37:729-34.
36. Morton DG, Lagasse LD. Pelvic lymphnodectomy as an adjunct to the radiation therapy of cervical carcinoma, Clin Obstet Gynecol 1967;10: 965-73.
37. Graham JB, Sotto LSJ, Paoloucek FP. Carcinoma of the cervix. Philadelphia: WB Saunders, 1962.
38. Baltzer J, Koepcke W. Tumor size and lymph node metastases in squamous cell carcinoma of the uterine cervix. Arch Gynecol 1979;227: 271-8.
39. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745-9.
40. Narayan K, Hicks RJ, Jobling T, et al. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001;11:263-71.
41. Fyles AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995;35:107-17.